Chronic Lymphedema:
an unmet clinical need
- Chronic limb swelling due to lymphatic vessel dysfunction
- Pain and recurrent infection
- No existing cure
Epidemiology
- 140 million people wordwide have lymphedema today
- Lymphedema is a common side effect of successful cancer therapies
- 1 in 4 breast cancer survivor develops lymphedema within 3 years from cancer removal surgery
Current Treatments
- Complete decongestive therapy (CDT): a combination of manual lymph drainage, compression therapy, exercise and skin care: lifelong lymphedema management (link)
- Optional home compression pumps
-
Experimental microsurgery:
- Lymphovenous anastomosis and lymph node transplant
- Liposuction- Silicone tubing bypass (link)
Our Competitive Advantage
- Technology: First implantable lymphatic drainage system
- Scalability: Standard surgical techniques for LymphoDrain implantation
-
Patient's quality of life:
- time saving
- compatible with daily activities
- seamless continuous internal drainage -
Cost reduction:
- Simple and fast ambulatory procedure
- Less hospital visits & physiotherapy sessions
Our Achievements
- Pilot clinical trial ongoing ( link to clinicaltrial.org)
- IP licence secured
- Development status: clinical prototype
- ISO 13485 certified (Download certificate here)
If you share our vision and want to invest in Lymphatica,
please contact us (contact@lymphatica.ch)
please contact us (contact@lymphatica.ch)